No Stock Yet
02367 GIANT BIOGENE
50.500-2.500-4.72%
NamePositionSalaryService DateEducationAgeGenderUpdated
严建亚Chairman of the nomination committee，CEO，Chairman of the Board，Executive director，Remuneration committee member，Authorized representative--11/30/2021Bachelor55male05/06/2022
范代娣Chief Scientific Officer，Executive director--07/28/2021Doctor56male05/06/2022
叶娟Executive director，Senior Vice President--11/30/2021Bachelor51female05/06/2022
方娟Senior Vice President，Executive director--11/30/2021College49female05/06/2022
陈锦浩Non-Executive Director--11/30/2021Master41male05/06/2022
黄进Nominating committee member，Independent non-executive director，Member of the audit committee--10/06/2022Doctor63male05/06/2022
单文华Chairman of the remuneration committee，Nominating committee member，Member of the audit committee，Independent non-executive director--10/06/2022Doctor--male05/06/2022
黄斯颖Independent non-executive director，Remuneration committee member，Chairman of the audit committee--10/06/2022Master43female05/06/2022
张慧娟CFO--04/21/2022Bachelor35female05/06/2022
严钰博Joint Company Secretary，Secretary of the board--04/21/2022Master26female05/06/2022
段志广Senior Vice President--04/21/2022Doctor41male08/18/2022
严亚娟Senior Vice President--04/21/2022Bachelor53female08/18/2022
姚淑娴Joint Company Secretary，Authorized representative--04/21/2022Master48female08/18/2022
Company Overview
More
Juzi Biotech Holdings Co., Ltd. is a Chinese investment holding company. Through its subsidiaries, the company is mainly engaged in the R&D, production and sale of beauty and health products based on bioactive materials. The company's main products include functional skincare products and medical dressings, and the key bioactive ingredient in its products is recombinant collagen. The company also develops and produces rare functional foods based on ginsenoside technology. The company mainly conducts its business in the domestic market.
CEO： Jianya Yan
Market： Hong Kong motherboard
Listing Date： 11/04/2022
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist